Erratum: Discovery and characterization of alamandine: A novel component of the renin-angiotensin system (Circulation Research (2013) 112 (1104-1111) DOI: 10.1161/CIRCRESAHA.113.301077);Discovery and characterization of alamandine: A novel component of the renin-angiotensin system

Circulation Research

Volumn 112, Issue 8, 2013, Pages 1104-1111

  Lautner, Roberto Queiroga ^a   Villela, Daniel C ^a   Fraga Silva, Rodrigo A ^a   Silva, Neiva ^a   Verano Braga, Thiago ^a,f   Costa Fraga, Fabiana ^a   Jankowski, Joachim ^b   Jankowski, Vera ^b   Sousa, Frederico ^a   Alzamora, Andreia ^a,c   Soares, Everton ^a,c   Barbosa, Claudiane ^a,c   Kjeldsen, Frank ^f   Oliveira, Aline ^a   Braga, Janaina ^a   Savergnini, Silvia ^a   Maia, Gisele ^a   Peluso, Antonio Bastos ^a   Passos Silva, Danielle ^a   Ferreira, Anderson ^a   Alves, Fabiana ^a   Martins, Almir ^a   Raizada, Mohan ^d   Paula, Renata ^a   Motta Santos, Daisy ^a   Kemplin, Friederike ^e   Pimenta, Adriano ^a   Alenina, Natalia ^e   Sinisterra, Ruben ^a   Bader, Michael ^e   Campagnole Santos, Maria Jose ^a   Santos, Robson A S ^a   more..

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

angiotensin II; antihypertensive treatment; cardiovascular system; hypertension; renin.angiotensin system; vascular reactivity; vasoactive peptides

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; ANTIFIBROTIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ALANINE; G PROTEIN COUPLED RECEPTOR; HEPTAPEPTIDE; ISOPRENALINE; MAS RELATED G PROTEIN COUPLED RECEPTOR; PROTEIN ALAMANDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CIRCULATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

EID: 84876407858     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e3182994fbd     Document Type: Erratum

References (30)

1. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
2. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238-33243.
3. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1-E9.
4. Santos RA, Simoes e Silva AC, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA. 2003;100:8258-8263.
5. Santiago NM, Guimarães PS, Sirvente RA, Oliveira LA, Irigoyen MC, Santos RA, Campagnole-Santos MJ. Lifetime overproduction of circulating Angiotensin-(1-7) attenuates deoxycorticosterone acetate-salt hypertension-induced cardiac dysfunction and remodeling. Hypertension. 2010;55:889-896.
6. Ferreira AJ, Castro CH, Guatimosim S, et al. Attenuation of isoproter-enol-induced cardiac fbrosis in transgenic rats harboring an angioten-sin-(1-7)-producing fusion protein in the heart. Ther Adv Cardiovasc Dis. 2010;4:83-96.
7. Nadu AP, Ferreira AJ, Reudelhuber TL, Bader M, Santos RA. Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1-7)3292 rats. J Am Soc Hypertens. 2008;2:341-348.
8. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res. 2008;103:1319-1326.
9. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol. 2007;292:H736-H742.
10. le Tran Y, Forster C. Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol. 1997;30:676-682.
11. Santos RA, Ferreira AJ, Nadu AP, Braga AN, de Almeida AP, Campagnole-Santos MJ, Baltatu O, Iliescu R, Reudelhuber TL, Bader M. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiol Genomics. 2004;17:292-299.
12. Coffman TM. Under pressure: the search for the essential mechanisms of hypertension. Nat Med. 2011;17:1402-1409.
13. Jankowski V, Vanholder R, van der Giet M, et al. Mass-spectrometric identifcation of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol. 2007;27:297-302.
14. Savergnini SQ, Beiman M, Lautner RQ, de Paula-Carvalho V, Allahdadi K, Pessoa DC, Costa-Fraga FP, Fraga-Silva RA, Cojocaru G, Cohen Y, Bader M, de Almeida AP, Rotman G, Santos RA. Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor. Hypertension. 2010;56:112-120.
15. Lula I, Denadai AL, Resende JM, de Sousa FB, de Lima GF, Pilo-Veloso D, Heine T, Duarte HA, Santos RA, Sinisterra RD. Study of angioten-sin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specifc NMR assignments and structural studies. Peptides. 2007;28:2199-2210.
16. Marques FD, Ferreira AJ, Sinisterra RD, Jacoby BA, Sousa FB, Caliari MV, Silva GA, Melo MB, Nadu AP, Souza LE, Irigoyen MC, Almeida AP, Santos RA. An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension. 2011;57:477-483.
17. Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B. Quantifcation of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics. 2004;4:1175-1186.
18. Herath CB, Mak K, Burrell LM, Angus PW. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver. Am J Physiol Gastrointest Liver Physiol. 2013;304:G99-108.
19. Silva DM, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RA, Lemos VS. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides. 2007;28:702-707.
20. Kluskens LD, Nelemans SA, Rink R, de Vries L, Meter-Arkema A, Wang Y, Walther T, Kuipers A, Moll GN, Haas M. Angiotensin-(1-7) with thio-ether bridge: an angiotensin-converting enzyme-resistant, potent angio-tensin-(1-7) analog. J Pharmacol Exp Ther. 2009;328:849-854.
21. Gembardt F, Grajewski S, Vahl M, Schultheiss HP, Walther T. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol Cell Biochem. 2008;319:115-123.
22. Shinohara T, Harada M, Ogi K, Maruyama M, Fujii R, Tanaka H, Fukusumi S, Komatsu H, Hosoya M, Noguchi Y, Watanabe T, Moriya T, Itoh Y, Hinuma S. Identifcation of a G protein-coupled receptor specifcally responsive to beta-alanine. J Biol Chem. 2004;279:23559-23564.
23. Milasta S, Pediani J, Appelbe S, Trim S, Wyatt M, Cox P, Fidock M, Milligan G. Interactions between the Mas-related receptors MrgD and MrgE alter signalling and traffcking of MrgD. Mol Pharmacol. 2006;69:479-491.
24. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12:70-88.
25. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA. 1995;92:10663-10667.
26. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional signifcance. Mol Pharmacol. 1990;38:370-377.
27. Walters PE, Gaspari TA, Widdop RE. Angiotensin-(1-7) acts as a va-sodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension. 2005;45:960-966.
28. Raffai G, Durand MJ, Lombard JH. Acute and chronic angioten-sin-(1-7) restores vasodilation and reduces oxidative stress in mes-enteric arteries of salt-fed rats. Am J Physiol Heart Circ Physiol. 2011;301:H1341-H1352.
29. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ. A diverse family of GPCRs expressed in specifc subsets of nociceptive sensory neurons. Cell. 2001;106:619-632.
30. Nishimura S, Uno M, Kaneta Y, Fukuchi K, Nishigohri H, Hasegawa J, Komori H, Takeda S, Enomoto K, Nara F, Agatsuma T. MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer. PLoS ONE. 2012;7:e38618.